HOPFINGER A J,WANG S,TOKARSKI J S,et al.Construction of 3DQSAR models using 4D-QSAR analysis formalism[J].J Am Chem Soc,1997,119(43):10509-10524.
[3]
PASTOR M,CRUCIANI G,MCLAY I,et al.Gridindpendent descriptors(GRIND):a novel class ofalignmentindependent three-dimensional descriptors[J].J Med Chem,2000,43(17):3233-3243.
[4]
ROBINSON A U,WINN P J,LYNE P D,et al.Selforganizing molecular field analysis:A tool for structure-activity studies[J].J.Med.Chem.,1999,42(4):573-583.
[5]
VEDANI A,BRIEM H,DOBLER M,et al.Multiple conformation and protonation-state representation in 4D-QSAR:TheNeurokinin-1 receptor system[J].J Med Chem,2000,43(23):4416-4427.
[6]
VEDANI A,DOBLER M.Multidimensional QSAR in drug research:Predicting binding affinities,toxicity,andpharmacokinetic parameters[C]∥Progress in Drug Research.Birkhauser:Boston,2000:105-135.
[7]
VEDANI A,MCMASTERS D R,DOBLER M.Multi-conformational ligand representation in 4D-QSAR:Reducing the biasassociated with ligand alignment[J].Quant Struct Act Relat,2000,19(2):149-161.
[8]
VEDANI A,DESCLOUX A V,SPREATICO M,et al.Predicting the toxic potential of drugs and chemicals in silico:Amodel for the peroxisome proliferator-activated receptor-gamma(PPAR gamma)[J].Toxi Lett,2007,173(1):17-23.
[9]
VEDANI A,DOBLER M,ZBINDEN P.Quasi-atomistic receptor surface models:A bridge between 3-D QSAR andreceptor modeling[J].J Am Chem Soc,1998,120(18):4471-4477.
[10]
HERNANDEZ M A,POWERS J C,GLINSKI J,et al.Effect of the 7-amino substituent on the inhibitory potency ofmechanism-based isocoumarin inhibitors for porcine pancreatic and human neutrophil elastases:a 1.85-X-ray structure ofthe complex between porcine pancreatic elastase and 7-[(N-tosylphenylalanyl)amino]-4-chloro-3-methoxyisocoumarin[J].JMed Chem,1992,35(6):1121-1129.
[11]
GHOSE A K,CRIPPEN G M.Atomic physicochemical parameters for three-dimensional structure-directed structure-activity relationshipsⅠ:Partition coefficients as a measure of hydrophobicity[J].J Comput Chem,1986,7(4):565-577.
[12]
VEDANI A,DOBLER M:5D-QSAR:the key for simulating induced fit[J].J Med Chem,2002,45(11):2139-2149.
[13]
VEDANI A,DOBLER M,DOLLINGER H,et al.Novel ligands for the chemokine receptor-3(CCR3):A receptor-modeling study based on 5D-QSAR[J].J Med Chem,2005,48(5):1515-1527.
[14]
DUCKI S,MACKENZIE G,LAWRENCE N J,et al.Quantitative structure-activity relationship(5D-QSAR)study ofcombretastatin-like analogues as inhibitors of tubulin assembly[J].J Med Chem,2005,48(2):457-465.
[15]
VEDANI A,DOBLER M,LILL M A.Combining protein modeling and 6D-QSAR Simulating the binding of structurallydiverse ligands to the estrogen receptor[J].J Med Chem,2005,48(11):3700-3703.
[16]
VEDANI A,DOBLER M.Quasar 5.0 user and reference manual[CP/OL].Friedensgasse 35,CH—4056 Basel,Switzerland:Biographics Laboratory 3 R,2005.http:∥www.biograf.ch/downloads/quasar.pdf.[2005-04-21].
[17]
BLANEY J M,WEINER P K,DEARING A,et al.Molecular mechanics simulation of protein-ligand interactions:Bindingof thyroid analogues to prealbumin[J].J Am Chem Soc,1982,104(23):6424-6434.
[18]
STILL W C,TEMPCZYK A,HAWLEY R C,et al.Semianalytical treatment of solvation for molecular mechanics anddynamics[J].J Am Chem Soc,1990,112(16):6127-6129.
[19]
VEDANI A,ZBINDEN P,SNYDER J P,et al.Pseudoreceptor modeling:The construction of three-dimensional receptorsurrogates[J].J Am Chem Soc,1995,117(17):4987-4994.
[20]
VEDANI A,HUHTA D W.A new force field for modeling metalloproteins[J].J Am Chem Soc,1990,112(12):4759-4767.
[21]
LI X,YU L M,WANG B J,et al.Synthesis and QSAR studies on anti-algae activities of novel ester derivatives containingindole ring[J].Acta Chimica Sinica,2008,66(22):2507-2512.
[22]
PERISTERA O,SPREAFICO M,SMIESKO M,et al.Mixed-model QSAR at the human mineralocorticoid receptor:Predicting binding mode and affinity of anabolic steroids[J].Toxi Lett,2009,189(3):219-224.
[23]
SO S S,KARPLUS M.Three-dimensional quantitative structureactivity relationships from molecular similarity matrixes andgenetic neural networks[J].J Med Chem,1997,40(26):4347-4359.
[24]
KUROGI Y,GUNER O F.Pharmacophore modeling and threedimensional database searching for drug design using“Catalyst”[J].Curr Med Chem,2001,8(9):1035-1055.
[25]
FURET P,SELE A,COHEN N C.3D molecular lipophilicity potential profiles:A new tool in molecular modeling[J].JMol Graphics,1988,6(4):182-189.
[26]
WALTERS D E,HINDS R M.Genetically evolved receptor models:A computational approach to construction of receptormodels[J].J Med Chem,1994,37(16):2527-2536.
[27]
ROGERS D,HOPFINGER A J.Genetic function approximation to generate a family of QSAR equations using geneticalgorithms[J].J.Chem Inf Comput Sci,1994,34(4):854-866.
[28]
VEDANI A,DOBLER M.Multidimensional QSAR:moving from three-to five-dimensional concepts[J].Quant Struct-ActRelat,2002,21(4):382-390.
[29]
SEARLE M S,WILLIAMS D H.The cost of conformational order:Entropy changes in molecular associations[J].J AmChem Soc,1992,114(27):10690-10697.
[30]
CHEN H,BAI J,JIAO L L,et al.Design,microwave-assisted synthesis and HIV-RT inhibitory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones[J].Bioorg Medi Chem,2009,17(11):3980-3986.
[31]
POLANSKI J.Receptor dependent multidimensional QSAR for modeling drug-receptor interactions[J].Curr Medi Chem,2009,16(25):3243-3257.
